News

Satsuma, a unit of a Japanese drugmaker with U.S. headquarters in Durham, said its treatment, called Atzumi, received its new ...
The High Court here has allowed an application by former Bersatu Youth chief Adam Asmuni to submit new evidence in his appeal ...
Pfizer also plans to make a $100 million equity investment in the Chinese biotechnolgoy company after the transaction closes, ...
Shares of biotech company UroGen Pharma Ltd. (URGN) plummeted 48% on Wednesday noon after the company said that a committee ...
On May 16, 2024, the CDE’s official website announced that the Application would be reviewed via the priority review and approval process. This marks the fourth sac-TMT indication to go through the ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...
Despite recent challenges ranging from wildfires to economic uncertainty, Los Angeles remains a prime destination, not only ...
The initiatives reflect the latest measures from federal agencies to reduce and ultimately replace animal testing in drug development and ...
If the initiative proceeds as planned, it will mark a pivotal shift in the regulatory landscape, introducing both efficiencies and novel ...
Apellis Pharmaceuticals focuses on creating medicines targeting eye diseases and rare neurological diseases. Read why I rate ...
The White House has launched a new program focused on leveraging technology and private sector partnerships to find new ways to quickly produce key pharmaceutical ingredients and finished drugs at the ...